China pharma industry unaffected by Beijing tech deal reviews, JW chief says
The head of JW stated that Beijing's review of sensitive technology transactions has not affected China's pharmaceutical sector. The comment addresses ongoing government scrutiny of certain deals.
finance.yahoo.comThe head of JW said China's pharmaceutical industry has not been affected by Beijing's examination of sensitive technology transactions. The statement comes as Chinese authorities continue to review certain deals involving advanced technology.
No specific transactions or regulatory actions were detailed in the remarks. The comments focused on the absence of measurable impact on pharmaceutical operations to date.
Key Facts
Transparency Panel
Related Stories
straitstimes.comJournalists in Gaza to Receive 2026 Golden Pen of Freedom Award
Three international news agencies will accept the award on behalf of their local staff still reporting from the territory. The World Association of News Publishers cited the journalists' continued coverage under extreme conditions.
upi.comSupreme Court Revives Havana Docks Lawsuit Over Confiscated Cuban Property
The U.S. Supreme Court sent a Helms-Burton Act case back to lower courts for further argument. The suit seeks damages from cruise lines that used docks seized by Cuba in 1959.
France 24Pakistan Population Growth Outpaces Infrastructure as Male Contraception Stays Taboo
Pakistan's population exceeds 258 million and could reach 300 million by 2030. Contraception remains largely taboo in a society shaped by traditional values. The country continues to lag behind neighbors India and Bangladesh in key social sectors.